Back

Cytoskeleton remodeling caused by keratin dysregulation triggers tumor aggressiveness via promoting genomic instability and cellular adaption

Chuang, H.-H.; Kuo, B. Y.-T.; Sriramadasu, K.; Lai, M.-T.; Lin, L. Y.-T.; Boominathan, P. K.; Hwang, T.; Chen, Y.-C.; Chen, C.-M.; Chang, C. Y.-Y.; Sheu, J. J.-C.

2025-11-04 cancer biology
10.1101/2025.11.03.686269 bioRxiv
Show abstract

Cellular architecture depends on keratin intermediate filament as a fundamental component, which offers essential mechanical support to fight environmental stresses. Our previous research demonstrated that keratin fusion variants increase tumor aggressiveness through enhanced cancer stemness in oral squamous cell carcinoma. The proper functioning of keratins plays an essential role in maintaining cell structure while determining cell fate. The present study demonstrates that keratin fusion variant drives genomic instability through cytokinesis defects, which results in the formation of polyaneuploid cancer cells (PACC). The cells expressing keratin fusion show elevated DNA damage repair gene expression, which serves as a key factor for mitotic slippage during cancer development. The PACCs generated by keratin fusion make cancer cells resistant to cisplatin treatment while simultaneously reducing {gamma}-H2AX induction and increasing survival rates. The Gene Set Enrichment Analysis results showed increased "regulation of actin cytoskeleton" activity in keratin fusion-expressing cells correlated with elevated actin filament networks and increased cell motility in these cells. In summary, the keratin fusion variant enhances cancer aggressiveness through three mechanisms: it creates genomic instability that leads to PACC formation and enables cancer cells to evade cGAS/STING-mediated death signals and modifies cytoskeleton structures, which results in drug resistance and metastasis.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Experimental Cell Research
28 papers in training set
Top 0.1%
12.3%
2
PLOS ONE
5266 papers in training set
Top 23%
7.2%
3
Cancers
213 papers in training set
Top 1%
5.5%
4
Cell Death & Disease
126 papers in training set
Top 0.5%
4.3%
5
International Journal of Molecular Sciences
494 papers in training set
Top 3%
4.0%
6
Genes to Cells
25 papers in training set
Top 0.1%
4.0%
7
eLife
5828 papers in training set
Top 32%
3.5%
8
Biochemistry and Biophysics Reports
30 papers in training set
Top 0.1%
3.2%
9
Oncogene
85 papers in training set
Top 0.7%
3.1%
10
Molecular Oncology
55 papers in training set
Top 0.4%
2.6%
11
Aging
75 papers in training set
Top 0.6%
2.4%
50% of probability mass above
12
Frontiers in Oncology
103 papers in training set
Top 2%
2.4%
13
Scientific Reports
3612 papers in training set
Top 45%
2.4%
14
Translational Oncology
21 papers in training set
Top 0.3%
2.1%
15
Cells
249 papers in training set
Top 2%
1.9%
16
Cell Death Discovery
58 papers in training set
Top 0.6%
1.7%
17
Cancer Letters
35 papers in training set
Top 0.5%
1.7%
18
Biomolecules
100 papers in training set
Top 1%
1.5%
19
Advanced Biology
29 papers in training set
Top 0.3%
1.5%
20
Biochemical and Biophysical Research Communications
84 papers in training set
Top 1%
1.4%
21
International Journal of Biological Macromolecules
76 papers in training set
Top 1%
1.3%
22
Cell Cycle
17 papers in training set
Top 0.2%
1.3%
23
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 4%
1.1%
24
Open Biology
106 papers in training set
Top 1%
1.1%
25
Heliyon
152 papers in training set
Top 6%
1.1%
26
PLOS Genetics
862 papers in training set
Top 11%
0.9%
27
Acta Neuropathologica Communications
89 papers in training set
Top 2%
0.8%
28
Oncogenesis
12 papers in training set
Top 0.4%
0.8%
29
Oncotarget
18 papers in training set
Top 0.5%
0.8%
30
Molecular and Cellular Biology
47 papers in training set
Top 0.9%
0.8%